Citadel Advisors’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-48,449
| Closed | -$4K | – | 7029 |
|
|
2022
Q3 | $4K | Sell |
48,449
-14,118
| -23% | -$1.17K | ﹤0.01% | 5723 |
|
|
2022
Q2 | $5K | Sell |
62,567
-304,560
| -83% | -$24.3K | ﹤0.01% | 5875 |
|
|
2022
Q1 | $73K | Sell |
367,127
-10,420
| -3% | -$2.07K | ﹤0.01% | 5785 |
|
|
2021
Q4 | $204K | Sell |
377,547
-7,137
| -2% | -$3.86K | ﹤0.01% | 5460 |
|
|
2021
Q3 | $230K | Buy |
384,684
+109,684
| +40% | +$65.6K | ﹤0.01% | 5285 |
|
|
2021
Q2 | $209K | Buy |
+275,000
| New | +$209K | ﹤0.01% | 5537 |
|